Xavier Electromyographic Wheelchair Control for Limited Mobility Patients
Not Applicable
Completed
- Conditions
- Amyotrophic Lateral Sclerosis
- Registration Number
- NCT04800926
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The purpose of this study is to assess the functional mobility and self-reported satisfaction with the Xavier electromyography hands-free wheelchair control system in comparison with a standard joystick.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 4
Inclusion Criteria
- ALS diagnosis by revised el Escorial criteria (definite, probable or probable laboratory supported)
- Age 18-89
- Limited mobility with use of motorized wheelchair at screening-time
- Impairment of hand function limiting the use of a standard joystick control
- Caregiver willing to assist with transfers into wheelchair and application of controllers
- Ability to attend study visits with a motorized wheelchair
- Ability to communicate and answer patient reported outcome measure questions
Exclusion Criteria
- Cognitive impairment prohibiting safe independent mobility as defined by an ALS-Cognitive Behavioral Screen (ALS-CBS) score of <10 or the opinion of the investigator
- A sensory impairment prohibiting safe independent mobility in the opinion of the investigator
- Allergy to adhesives or electrode gels (required for EMG electrodes)
- Skin breakdown over the temporalis muscle that would predispose to further breakdown and/or infection with electrodes
- Severe loss of facial muscle functionality or control that would preclude EMG electrode efficacy
- Subjects who do not have the capacity to consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Wheelchair Skills Test (WST) approximately 3 days Questionnaire
- Secondary Outcome Measures
Name Time Method Drive test approximately 3 days Driving around cones in a controlled environment
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of electromyography-based wheelchair control in ALS patients?
How does the Xavier controller compare to standard joysticks in functional mobility outcomes for ALS patients?
Are there specific biomarkers that predict response to hands-free wheelchair control systems in motor neuron diseases?
What adverse events are associated with electromyographic wheelchair interfaces in limited mobility populations?
What are the key design features of the Xavier device that differentiate it from other EMG-based mobility solutions?
Trial Locations
- Locations (1)
Mayo Clinic in Florida
🇺🇸Jacksonville, Florida, United States
Mayo Clinic in Florida🇺🇸Jacksonville, Florida, United States